Anti-angiogenic activity of neurokinin B
Anti-angiogenic activity of neurokinin B
批准号:
7906655
负责人:
Soumen Paul
金额:
$18.75万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-05 至 2012-07-31
关键词:
ActinsAddressBiological AssayBiological ProcessBlood VesselsCDC42 geneChickensChromatinDefectDevelopmentDiseaseEmbryonic DevelopmentEndothelial CellsEventFamilyFibroblast Growth Factor 2Focal Adhesion Kinase 1Focal AdhesionsGenesGenetic TranscriptionGleanGrowth and Development functionGuanosine Triphosphate PhosphohydrolasesHypoxia Inducible FactorIn VitroInstitutesLeadMediatingMembraneMessenger RNAModalityMolecularMorphogenesisNeoplasm MetastasisNervous system structureNeurokinin BNucleic Acid Regulatory SequencesOrganPeptidesPhosphorylationPhysiological ProcessesPre-EclampsiaPregnancyProteinsRNA InterferenceRegulationReproductionRodentRoleSignal PathwaySignal TransductionTachykininTestingTimeTranscriptional ActivationTranscriptional RegulationTubular formationTumor AngiogenesisTyrosineVascular Endothelial CellVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsWound Healingangiogenesisbasecell motilitychorioallantoic membranechromatin immunoprecipitationcombinatorialhuman BCAR1 proteinin vivoknock-downmRNA Expressionmatrigelmembermigrationnovel therapeuticsoverexpressionpaxillinpublic health relevanceresponserhotranscription factortumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neurokinin B (NK-B) is a member of tachykinin family of peptides. Classically, NK-B expression and function was studied in the context of the nervous system. However overexpression of NK-B has been implicated in the pregnancy-associated disorder preeclampsia, which is characterized by defective remodeling of the placental vasculature and systemic vascular deregulation. We demonstrated that NK-B reversibly inhibits endothelial cell vascular network assembly in vitro on Matrigel and opposes angiogenesis in vivo. Mechanistic analyses revealed that NK-B signaling inhibited angiogenic signal-induced expression of vascular endothelial growth factor receptor1 (VEGFR1) and VEGFR2, and reduced endothelial cell migration. The objective of this proposal is to determine the regulatory mechanisms, by which NK-B inhibits angiogenic signal-induced VEGFR1 and VEGFR2 induction, and endothelial cell migration. We will institute two specific aims to address this. In the first Specific Aim we will determine how neurokinin B represses angiogenic signal-dependent VEGFR induction. Transcription factors Ets1 and HIF-2alpha have been implicated in the transcriptional regulation of VEGFR1 and VEGFR2. We will test whether Ets1 and HIF-2alpha directly activate transcription of VEGFR1 and VEGFR2 in response to angiogenic signals in vitro and in vivo, and whether NK-B signaling represses transcription by blocking Ets1/HIF-2alpha chromatin occupancy or a critical function post-occupancy. In the second Specific Aim we will determine the mechanism of NK-B-mediated inhibition of endothelial cell migration. We hypothesize that, in endothelial cells, NK-B signaling modulates critical signaling pathways that mediate directed cell migration. To test this hypothesis we will document signal transduction events in endothelial cells stimulated to undergo migration and the effect of NK-B on those events, including phosphorylation of focal adhesion kinase, paxillin, p130Cas, spatial and temporal association of these molecules to form focal adhesions, and activation of Rho family of GTPases Rac1 and CDC42. PUBLIC HEALTH RELEVANCE: Angiogenesis, the development of new blood vessels from existing vasculature, is a key event in many physiological processes, like organ growth and development, wound healing, and reproduction. Angiogenesis is also critical for certain pathological disorders including tumor growth/metastasis. Information gleaned from these studies will contribute to our understanding of the molecular mechanisms of angiogenesis and hopefully will lead to novel therapeutic modalities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modeling Human Placentation via Single Cell RNA-Sequencing
-
批准号:10448457
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2021
-
负责人:Soumen Paul
-
依托单位:
Histone Demethylases and Trophoblast Differentiationt
-
批准号:10239804
-
项目类别:
-
资助金额:$42.82万
-
财政年份:2021
-
负责人:Soumen Paul
-
依托单位:
Histone Demethylases and Trophoblast Differentiationt
-
批准号:10663896
-
项目类别:
-
资助金额:$43.07万
-
财政年份:2021
-
负责人:Soumen Paul
-
依托单位:
Modeling Human Placentation via Single Cell RNA-Sequencing
-
批准号:10316877
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2021
-
负责人:Soumen Paul
-
依托单位:
Histone Demethylases and Trophoblast Differentiationt
-
批准号:10459451
-
项目类别:
-
资助金额:$43.07万
-
财政年份:2021
-
负责人:Soumen Paul
-
依托单位:
Hippo Signaling Effector and Placentation
-
批准号:10377390
-
项目类别:
-
资助金额:$45.53万
-
财政年份:2020
-
负责人:Soumen Paul
-
依托单位:
Hippo Signaling Effector and Placentation
-
批准号:10610860
-
项目类别:
-
资助金额:$45.53万
-
财政年份:2020
-
负责人:Soumen Paul
-
依托单位:
Atypical protein kinase C signaling and placentation
-
批准号:9903417
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2019
-
负责人:Soumen Paul
-
依托单位:
Atypical protein kinase C signaling and placentation
-
批准号:9765590
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2019
-
负责人:Soumen Paul
-
依托单位:
RESEARCH PROJECT I: TEAD4 Orchestration of Trophoblast Development
-
批准号:8897428
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2015
-
负责人:Soumen Paul
-
依托单位:
RESEARCH PROJECT I: TEAD4 Orchestration of Trophoblast Development
-
批准号:8743037
-
项目类别:
-
资助金额:$28.27万
-
财政年份:2014
-
负责人:Soumen Paul
-
依托单位:
TEAD4 and Trophoblast Lineage
-
批准号:8583638
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2013
-
负责人:Soumen Paul
-
依托单位:
TEAD4 and Trophoblast Lineage
-
批准号:8706196
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2013
-
负责人:Soumen Paul
-
依托单位:
Histone Chaperones in Angiogenesis
-
批准号:8213406
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2011
-
负责人:Soumen Paul
-
依托单位:
Histone Chaperones in Angiogenesis
-
批准号:8028320
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2011
-
负责人:Soumen Paul
-
依托单位:
Protein Kinase C Signaling and Pluripotent Stem Cell
-
批准号:8191717
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2011
-
负责人:Soumen Paul
-
依托单位:
Protein Kinase C Signaling and Pluripotent Stem Cell
-
批准号:8315981
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2011
-
负责人:Soumen Paul
-
依托单位:
TRANSCRIPTIONAL MECHANISMS OF ENDOTHELIAL FUNCTION AND DIFFERENTIATION
-
批准号:8360684
-
项目类别:
-
资助金额:$21.66万
-
财政年份:2011
-
负责人:Soumen Paul
-
依托单位:
GATA Factor Function in Trophoblast
-
批准号:10155098
-
项目类别:
-
资助金额:$43.9万
-
财政年份:2010
-
负责人:Soumen Paul
-
依托单位:
GATA Factor Function in Trophoblast
-
批准号:8678721
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2010
-
负责人:Soumen Paul
-
依托单位:
海外基金